- A Bulletin article on DIY vaccines during the pandemic was shared, prompting debate over whether decentralized, early-access vaccination could have saved lives versus the regulatory insistence on full-scale trials.  
- Participants argued that Pfizer’s raw data already showed clear protective effects within weeks, suggesting vulnerable sub-populations should have received emergency doses months earlier.  
- The FDA’s decision to restart pediatric trials with larger cohorts to detect one-in-a-million myocarditis cases was criticized as causing more child deaths from COVID than it could ever prevent.  
- The discussion framed regulatory delay as a systemic failure rooted in bureaucratic risk aversion: officials fear personal liability for rare adverse events more than the statistical certainty of mass casualties.  
- Practical consequences were highlighted: elementary schools reopened under the false premise that vaccine mandates would protect students, despite 100 % of 5–11-year-olds remaining unvaccinated at the time.  
- Links referenced: Bulletin article “Do-it-yourself vaccines in a pandemic: democratized science or home-brewed pipe dream?” and the open-source OpenPGP.js cryptographic library (https://openpgpjs.org/).